Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Originalspråk	engelska
Sidor (från-till)	1595-1596
Antal sidor	2
Tidskrift	The New England journal of medicine
Volym	381
Nummer	16
DOI	https://doi.org/10.1056/NEJMc1910735
Status	Published - 2019 okt. 17

Ämnesklassifikation (UKÄ)

@article{9c577070100c4b7e9d2b5626d376ccd8,

title = "Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease",

author = "Kristofer Andr{\'e}asson and Wuttge, {Dirk M.} and Wollheim, {Frank A.}",

year = "2019",

month = oct,

day = "17",

doi = "10.1056/NEJMc1910735",

language = "English",

volume = "381",

pages = "1595--1596",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "16",

}

TY - JOUR

T1 - Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

AU - Andréasson, Kristofer

AU - Wuttge, Dirk M.

AU - Wollheim, Frank A.

PY - 2019/10/17

Y1 - 2019/10/17

U2 - 10.1056/NEJMc1910735

DO - 10.1056/NEJMc1910735

M3 - Letter

C2 - 31618555

SN - 0028-4793

VL - 381

SP - 1595

EP - 1596

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 16

ER -